Works by Jelinek, Diane


Results: 45
    1
    2
    3

    Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 11, p. 3031, doi. 10.3109/10428194.2015.1023800
    By:
    • Lucas, David M.;
    • Ruppert, Amy S.;
    • Lozanski, Gerard;
    • Dewald, Gordon W.;
    • Lozanski, Arletta;
    • Claus, Rainer;
    • Plass, Christoph;
    • Flinn, Ian W.;
    • Neuberg, Donna S.;
    • Paietta, Elisabeth M.;
    • Bennett, John M.;
    • Jelinek, Diane F.;
    • Gribben, John G.;
    • Hussein, Mohamad A.;
    • Appelbaum, Frederick R.;
    • Larson, Richard A.;
    • Moore, Dennis F.;
    • Tallman, Martin S.;
    • Byrd, John C.;
    • Grever, Michael R.
    Publication type:
    Article
    4

    Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 8, p. 759, doi. 10.1002/ajh.24762
    By:
    • Larsen, Jeremy T.;
    • Shanafelt, Tait D.;
    • Leis, Jose F.;
    • LaPlant, Betsy;
    • Call, Tim;
    • Pettinger, Adam;
    • Hanson, Curtis;
    • Erlichman, Charles;
    • Habermann, Thomas Matthew;
    • Reeder, Craig;
    • Nikcevich, Daniel;
    • Bowen, Deborah;
    • Conte, Michael;
    • Boysen, Justin;
    • Secreto, Charla;
    • Lesnick, Connie;
    • Tschumper, Renee;
    • Jelinek, Diane;
    • Kay, Neil E.;
    • Ding, Wei
    Publication type:
    Article
    5

    Genomic characterization of chronic lymphocytic leukemia in patients of African ancestry.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-024-01207-3
    By:
    • Bonolo de Campos, Cecilia;
    • McCabe, Chantal E.;
    • Bruins, Laura A.;
    • O'Brien, Daniel R.;
    • Brown, Sochilt;
    • Tschumper, Renee C.;
    • Allmer, Cristine;
    • Zhu, Yuan Xiao;
    • Rabe, Kari G.;
    • Parikh, Sameer A.;
    • Kay, Neil E.;
    • Yan, Huihuang;
    • Cerhan, James R.;
    • Allan, John N.;
    • Furman, Richard R.;
    • Weinberg, J. Brice;
    • Brander, Danielle M.;
    • Jelinek, Diane F.;
    • Chesi, Marta;
    • Slager, Susan L.
    Publication type:
    Article
    6
    7

    Spatially defined intratumoral immune biomarkers predict recurrent versus second primary tumors in non-small cell lung cancer.

    Published in:
    Precision Clinical Medicine, 2025, v. 8, n. 1, p. 1, doi. 10.1093/pcmedi/pbaf001
    By:
    • Mudappathi, Rekha;
    • Maguire, Alanna;
    • Yi, Eunhee S;
    • Peng, Yanmei;
    • Kachergus, Jennifer M;
    • Khoor, Andras;
    • Tan, Kexin;
    • Zaniletti, Isabella;
    • Wampfler, Jason A;
    • Lou, Yanyan;
    • Reck dos Santos, Pedro A;
    • D'Cunha, Jonathan;
    • Sun, Zhifu;
    • Liu, Li;
    • Jelinek, Diane F;
    • Wang, Junwen;
    • Tazelaar, Henry D;
    • Thompson, E A;
    • Yang, Ping
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia.

    Published in:
    Immunogenetics, 2015, v. 67, n. 1, p. 61, doi. 10.1007/s00251-014-0812-3
    By:
    • Xochelli, Aliki;
    • Agathangelidis, Andreas;
    • Kavakiotis, Ioannis;
    • Minga, Evangelia;
    • Sutton, Lesley;
    • Baliakas, Panagiotis;
    • Chouvarda, Ioanna;
    • Giudicelli, Véronique;
    • Vlahavas, Ioannis;
    • Maglaveras, Nikos;
    • Bonello, Lisa;
    • Trentin, Livio;
    • Tedeschi, Alessandra;
    • Panagiotidis, Panagiotis;
    • Geisler, Christian;
    • Langerak, Anton;
    • Pospisilova, Sarka;
    • Jelinek, Diane;
    • Oscier, David;
    • Chiorazzi, Nicholas
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    A-Miz-ing BCL6.

    Published in:
    Nature Immunology, 2005, v. 6, n. 10, p. 964, doi. 10.1038/ni1005-964
    By:
    • Xiaosheng Wu;
    • Jelinek, Diane F.
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38

    Myeloma Immune and Antibody Targets.

    Published in:
    Clinical Lymphoma & Myeloma, 2009, v. 9, p. S18
    By:
    • Yi, Qing;
    • Jelinek, Diane F.;
    • Dhodapkar, Madhav V.;
    • Tai, Yu-Tzu;
    • Sahota, Surinder S.
    Publication type:
    Article
    39
    40
    41
    42
    43

    Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia.

    Published in:
    British Journal of Haematology, 2003, v. 121, n. 2, p. 287, doi. 10.1046/j.1365-2141.2003.04265.x
    By:
    • Dewald, Gordon W.;
    • Brockman, Stephanie R.;
    • Paternoster, Sarah F.;
    • Bone, Nancy D.;
    • O'Fallon, Judith R.;
    • Allmer, Cristine;
    • James, Charles D.;
    • Jelinek, Diane F.;
    • Tschumper, Renee C.;
    • Hanson, Curtis A.;
    • Pruthi, Rajiv K.;
    • Witzig, Thomas E.;
    • Call, Timothy G.;
    • Kay, Neil E.
    Publication type:
    Article
    44
    45